Name: generation of patient-derived podocytes from skin biopsies
Uploaded: 2023-05-26T13:20:00.000+00:00
Duration: 8 min 52 s
Description: Watch this Scientific Journal Video about Generation of Patient-Derived Podocytes from Skin Biopsies at JoVE.com

This work was funded by the Interdisciplinary Center for Clinical Research (IZKF) of Friedrich-Alexander University Erlangen-N&#252;rnberg with the grant number M4-IZKF-F009 given to Janina M&#252;ller-Deile, and by Bundesministerium f&#252;r Bildung und Forschung (BMBF) under the project name STOP-FSGS-Speed Translation-Oriented Progress to Treat FSGS, grant number 01GM2202D given to Janina M&#252;ller-Deile. We thank Annalena Kraus for the support in taking SEM images.

Using Skin Biopsies to Generate Patient-Derived Podocytes

<ol>
	<li>Mundel, P., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Rearrangements+of+the+cytoskeleton+and+cell+contacts+induce+process+formation+during+differentiation+of+conditionally+immortalized+mouse+podocyte+cell+lines.">Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines.</a> Experimental Cell Research. 236 (1), 248-258 (1997).</li><li>Grgic, I., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Imaging+of+podocyte+foot+processes+by+fluorescence+microscopy.">Imaging of podocyte foot processes by fluorescence microscopy.</a> Journal of the American Society of Nephrology. 23 (5), 785-791 (2012).</li><li>Grahammer, F., Schell, C., Huber, T. B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+podocyte+slit+diaphragm-from+a+thin+grey+line+to+a+complex+signalling+hub.">The podocyte slit diaphragm-from a thin grey line to a complex signalling hub.</a> Nature Reviews Nephrology. 9 (10), 587-598 (2013).</li><li>Deen, W. M., Lazzara, M. J., Myers, B. D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Structural+determinants+of+glomerular+permeability.">Structural determinants of glomerular permeability.</a> American Journal of Physiology. Renal Physiology. 281 (4), F579-F596 (2001).</li><li>Schell, C., Huber, T. B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+evolving+complexity+of+the+podocyte+cytoskeleton.">The evolving complexity of the podocyte cytoskeleton.</a> Journal of the American Society of Nephrology. 28 (11), 3166-3174 (2017).</li><li>Muller-Deile, J., Schiffer, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Podocyte+directed+therapy+of+nephrotic+syndrome-can+we+bring+the+inside+out.">Podocyte directed therapy of nephrotic syndrome-can we bring the inside out.</a> Pediatric Nephrology. 31 (3), 393-405 (2016).</li><li>Boehlke, C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Hantavirus+infection+with+severe+proteinuria+and+podocyte+foot-process+effacement.">Hantavirus infection with severe proteinuria and podocyte foot-process effacement.</a> American Journal of Kidney Diseases. 64 (3), 452-456 (2014).</li><li>Schiffer, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Pharmacological+targeting+of+actin-dependent+dynamin+oligomerization+ameliorates+chronic+kidney+disease+in+diverse+animal+models.">Pharmacological targeting of actin-dependent dynamin oligomerization ameliorates chronic kidney disease in diverse animal models.</a> Nature Medicine. 21 (6), 601-609 (2015).</li><li>Kopp, J. B., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Podocytopathies.">Podocytopathies.</a> Nature Reviews. Disease Primers. 6 (1), 68 (2020).</li><li>Wiggins, R. C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+spectrum+of+podocytopathies:+a+unifying+view+of+glomerular+diseases.">The spectrum of podocytopathies: a unifying view of glomerular diseases.</a> Kidney International. 71 (12), 1205-1214 (2007).</li><li>Mundel, P., Reiser, J., Kriz, W. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Induction+of+differentiation+in+cultured+rat+and+human+podocytes.">Induction of differentiation in cultured rat and human podocytes.</a> Journal of the American Society of Nephrology. 8 (5), 697-705 (1997).</li><li>Jat, P. S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Direct+derivation+of+conditionally+immortal+cell+lines+from+an+H-2Kb-tsA58+transgenic+mouse.">Direct derivation of conditionally immortal cell lines from an H-2Kb-tsA58 transgenic mouse.</a> Proceedings of the National Academy of Sciences. 88 (12), 5096-5100 (1991).</li><li>Saleem, M. A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+conditionally+immortalized+human+podocyte+cell+line+demonstrating+nephrin+and+podocin+expression.">A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression.</a> Journal of the American Society of Nephrology. 13 (3), 630-638 (2002).</li><li>Eto, N., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Podocyte+protection+by+darbepoetin:+preservation+of+the+cytoskeleton+and+nephrin+expression.">Podocyte protection by darbepoetin: preservation of the cytoskeleton and nephrin expression.</a> Kidney International. 72 (4), 455-463 (2007).</li><li>Krtil, J., Platenik, J., Kazderova, M., Tesar, V., Zima, T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Culture+methods+of+glomerular+podocytes.">Culture methods of glomerular podocytes.</a> Kidney &amp; Blood Pressure Research. 30 (3), 162-174 (2007).</li><li>Chittiprol, S., Chen, P., Petrovic-Djergovic, D., Eichler, T., Ransom, R. F. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Marker+expression,+behaviors,+and+responses+vary+in+different+lines+of+conditionally+immortalized+cultured+podocytes.">Marker expression, behaviors, and responses vary in different lines of conditionally immortalized cultured podocytes.</a> American Journal of Physiology. Renal Physiology. 301 (3), F660-F671 (2011).</li><li>Shih, N. Y., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=CD2AP+localizes+to+the+slit+diaphragm+and+binds+to+nephrin+via+a+novel+C-terminal+domain.">CD2AP localizes to the slit diaphragm and binds to nephrin via a novel C-terminal domain.</a> The American Journal of Pathology. 159 (6), 2303-2308 (2001).</li><li>Yan, K., Khoshnoodi, J., Ruotsalainen, V., Tryggvason, K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=N-linked+glycosylation+is+critical+for+the+plasma+membrane+localization+of+nephrin.">N-linked glycosylation is critical for the plasma membrane localization of nephrin.</a> Journal of the American Society of Nephrology. 13 (5), 1385-1389 (2002).</li><li>Sir Elkhatim, R., Li, J. Y., Yong, T. Y., Gleadle, J. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Dipping+your+feet+in+the+water:+podocytes+in+urine.">Dipping your feet in the water: podocytes in urine.</a> Expert Review of Molecular Diagnostics. 14 (4), 423-437 (2014).</li><li>Camici, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Urinary+detection+of+podocyte+injury.">Urinary detection of podocyte injury.</a> Biomedicine &amp; Pharmacotherapy. 61 (5), 245-249 (2007).</li><li>Muller-Deile, J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Overexpression+of+preeclampsia+induced+microRNA-26a-5p+leads+to+proteinuria+in+zebrafish.">Overexpression of preeclampsia induced microRNA-26a-5p leads to proteinuria in zebrafish.</a> Scientific Reports. 8 (1), 3621 (2018).</li><li>Schenk, H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Removal+of+focal+segmental+glomerulosclerosis+(FSGS)+factor+suPAR+using+CytoSorb.">Removal of focal segmental glomerulosclerosis (FSGS) factor suPAR using CytoSorb.</a> Journal of Clinical Apheresis. 32 (6), 444-452 (2017).</li><li>Petermann, A., Floege, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Podocyte+damage+resulting+in+podocyturia:+a+potential+diagnostic+marker+to+assess+glomerular+disease+activity.">Podocyte damage resulting in podocyturia: a potential diagnostic marker to assess glomerular disease activity.</a> Nephron. Clinical Practice. 106 (2), c61-c66 (2007).</li><li>Vogelmann, S. U., Nelson, W. J., Myers, B. D., Lemley, K. V. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Urinary+excretion+of+viable+podocytes+in+health+and+renal+disease.">Urinary excretion of viable podocytes in health and renal disease.</a> American Journal of Physiology. Renal Physiology. 285 (1), F40-F48 (2003).</li><li>Petermann, A. T., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Podocytes+that+detach+in+experimental+membranous+nephropathy+are+viable.">Podocytes that detach in experimental membranous nephropathy are viable.</a> Kidney International. 64 (4), 1222-1231 (2003).</li><li>Sakairi, T., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Conditionally+immortalized+human+podocyte+cell+lines+established+from+urine.">Conditionally immortalized human podocyte cell lines established from urine.</a> American Journal of Physiology. Renal Physiology. 298 (3), F557-F567 (2010).</li><li>Rauch, C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Differentiation+of+human+iPSCs+into+functional+podocytes.">Differentiation of human iPSCs into functional podocytes.</a> PLoS One. 13 (9), e0203869 (2018).</li><li>Musah, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Mature+induced-pluripotent-stem-cell-derived+human+podocytes+reconstitute+kidney+glomerular-capillary-wall+function+on+a+chip.">Mature induced-pluripotent-stem-cell-derived human podocytes reconstitute kidney glomerular-capillary-wall function on a chip.</a> Nature Biomedical Engineering. 1, 0069 (2017).</li><li>Takahashi, K., Okita, K., Nakagawa, M., Yamanaka, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Induction+of+pluripotent+stem+cells+from+fibroblast+cultures.">Induction of pluripotent stem cells from fibroblast cultures.</a> Nature Protocols. 2 (12), 3081-3089 (2007).</li><li>Takahashi, K., Yamanaka, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Induction+of+pluripotent+stem+cells+from+mouse+embryonic+and+adult+fibroblast+cultures+by+defined+factors.">Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.</a> Cell. 126 (4), 663-676 (2006).</li><li>Teshigawara, R., Cho, J., Kameda, M., Tada, T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Mechanism+of+human+somatic+reprogramming+to+iPS+cell.">Mechanism of human somatic reprogramming to iPS cell.</a> Laboratory Investigation. 97 (10), 1152-1157 (2017).</li><li>Bang, J. S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Optimization+of+episomal+reprogramming+for+generation+of+human+induced+pluripotent+stem+cells+from+fibroblasts.">Optimization of episomal reprogramming for generation of human induced pluripotent stem cells from fibroblasts.</a> Animal Cells and Systems. 22 (2), 132-139 (2018).</li><li>Okita, K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+more+efficient+method+to+generate+integration-free+human+iPS+cells.">A more efficient method to generate integration-free human iPS cells.</a> Nature Methods. 8 (5), 409-412 (2011).</li><li>Musah, S., Dimitrakakis, N., Camacho, D. M., Church, G. M., Ingber, D. E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Directed+differentiation+of+human+induced+pluripotent+stem+cells+into+mature+kidney+podocytes+and+establishment+of+a+Glomerulus+Chip.">Directed differentiation of human induced pluripotent stem cells into mature kidney podocytes and establishment of a Glomerulus Chip.</a> Nature Protocols. 13 (7), 1662-1685 (2018).</li><li>Burt, M., Bhattachaya, R., Okafor, A. E., Musah, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Guided+differentiation+of+mature+kidney+podocytes+from+human+induced+pluripotent+stem+cells+under+chemically+defined+conditions.">Guided differentiation of mature kidney podocytes from human induced pluripotent stem cells under chemically defined conditions.</a> Journal of Visualized Experiments. (161), e61299 (2020).</li><li>Vangipuram, M., Ting, D., Kim, S., Diaz, R., Schule, B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Skin+punch+biopsy+explant+culture+for+derivation+of+primary+human+fibroblasts.">Skin punch biopsy explant culture for derivation of primary human fibroblasts.</a> Journal of Visualized Experiments. (77), e3779 (2013).</li><li>Hoffding, M. K., Hyttel, P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Ultrastructural+visualization+of+the+Mesenchymal-to-Epithelial+Transition+during+reprogramming+of+human+fibroblasts+to+induced+pluripotent+stem+cells.">Ultrastructural visualization of the Mesenchymal-to-Epithelial Transition during reprogramming of human fibroblasts to induced pluripotent stem cells.</a> Stem Cell Research. 14 (1), 39-53 (2015).</li><li>Bharathan, S. P., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Systematic+evaluation+of+markers+used+for+the+identification+of+human+induced+pluripotent+stem+cells.">Systematic evaluation of markers used for the identification of human induced pluripotent stem cells.</a> Biology Open. 6 (1), 100-108 (2017).</li><li>Scholzen, T., Gerdes, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+Ki-67+protein:+from+the+known+and+the+unknown.">The Ki-67 protein: from the known and the unknown.</a> Journal of Cellular Physiology. 182 (3), 311-322 (2000).</li><li>Sun, X., Kaufman, P. D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Ki-67:+more+than+a+proliferation+marker.">Ki-67: more than a proliferation marker.</a> Chromosoma. 127 (2), 175-186 (2018).</li><li>Vaz, I. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Chromosomal+aberrations+after+induced+pluripotent+stem+cells+reprogramming.">Chromosomal aberrations after induced pluripotent stem cells reprogramming.</a> Genetics and Molecular Biology. 44 (3), 20200147 (2021).</li><li>Reiser, J., Altintas, M. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Podocytes.">Podocytes.</a> F1000Research. 5, 114 (2016).</li><li>Ohmori, T., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Impaired+NEPHRIN+localization+in+kidney+organoids+derived+from+nephrotic+patient+iPS+cells.">Impaired NEPHRIN localization in kidney organoids derived from nephrotic patient iPS cells.</a> Scientific Reports. 11 (1), 3982 (2021).</li><li>Morizane, R., Bonventre, J. V. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Generation+of+nephron+progenitor+cells+and+kidney+organoids+from+human+pluripotent+stem+cells.">Generation of nephron progenitor cells and kidney organoids from human pluripotent stem cells.</a> Nature Protocols. 12 (1), 195-207 (2017).</li></ol>

The authors have nothing to disclose.

This cell culture-based protocol combines the episomal reprogramming of human dermal fibroblasts into patient-specific hiPSCs and subsequent differentiation into hiPSC-derived podocytes. This allows us to study mutation-related alterations of podocytes from patients with genetic glomerular disease regarding podocyte injury. The protocol to reprogram dermal fibroblasts with an integration-free method by electroporation is adapted from the published work of Bang et al.32 and Okita et al.33. The protocol to differentiate podocytes from hiPSCs is adapted from the published protocol from Musah et al.28,34,35. There are already publications available describing the generation of podocytes from hiPSCs27,34,35. However, the protocol provided here is optimized and less expensive regarding the differentiation of hiPSCs into podocytes. Compared to the published protocol from Musah et al., we tested this protocol on different coating reagents, like vitronectin, laminin silk-511, and solubilized basement membrane matrix. The concentrations of vitronectin and laminin silk-511 could be decreased to 2.5 &#181;g/mL instead of 5 &#181;g/mL28,34,35. Furthermore, it was possible to decrease the concentrations of BMP7 and activin A-two very expensive growth factors-by 50%, from 100 ng/mL to 50 ng/mL.
This enables less expensive differentiation. Nephron progenitor cells from day 7 were still proliferating, and the possibility of freezing was shown before. We expanded these cells after thawing and before final differentiation in basic medium containing Dulbecco&#39;s modified Eagle medium (DMEM) and B27 for several days, decreasing the costs even further. In addition to the differentiation steps, this protocol describes the outgrowth of fibroblasts from skin biopsies with subsequent generation of patient-specific hiPSCs via episomal reprogramming. The combination of these two methods enables the generation of patient-specific podocytes. Therefore, a complete step-by-step protocol to generate patient-specific hiPSC-derived podocytes is provided here that was not described before in such detail.
As the overall protocol includes several different cell types, it is crucial to characterize the generated cell types at different steps. Cells are in culture for an extended period of time, so quality control should be performed at different passages. When working with hiPSCs, daily feeding as well as cell behavior and morphology monitoring is necessary. Sterility of the differentiation media must be ensured by filter sterilization through a 0.2 &#181;m filter. The whole protocol, from skin biopsy to hiPSC-derived podocytes, takes several months, but it is possible to freeze the cells at distinct stages of the process. Fibroblasts, selected hiPSC clones, and proliferative nephron progenitor cells after 7 days in nephron progenitor differentiation medium can be frozen, and a working cell bank can be generated.
Even though hiPSC-derived healthy podocytes develop a distinct network of primary and secondary foot processes (Figure 5A,B) and express&#160;typical podocyte-specific marker (Figure 6A-C), characteristic slit diaphragms, as seen in vivo, are hard to mimic in classical two-dimensional cell culture models. Moreover, intercell communication with other glomerular cell types is not possible in this mono-culture setting.
Due to their terminal differentiated state and lack of proliferation capacity, it is difficult to study podocytes ex vivo. With the help of conditionally immortalizing primary podocytes, it is possible to overcome this limitation by the insertion of a thermosensitive switch, resulting in a cell culture model where cells proliferate at 33 &#176;C and differentiate at 37 &#176;C13,14. Although these ciPodocytes have high potential for podocyte research, there are limitations, like the lack of marker expression, dedifferentiated morphology, and failure to form foot processes15,16.
The differentiation of podocytes from patient-derived somatic cells enables the generation and comparison of diseased podocytes with healthy control cells ex vivo. This enables us to study podocyte damage due to mutations in podocyte-specific genes. Furthermore, working with hiPSCs has the potential for creating three-dimensional cell culture disease models, or rather organoids43,44. Co-culture of hiPSC-derived podocytes with other glomerular cells, like glomerular endothelial cells or mesangial cells, might lead to new insights regarding intercell communication in health and glomerular disease.
Moreover, the characterization and treatment of the patient-specific podocytes can be performed ex vivo in high-throughput analysis. The individualized approach opens the opportunity to investigate novel therapeutic targets for specific mutations and to perform individualized medicine in the future.

Podocytes are specialized, post-mitotic renal epithelial cells that form the glomerular filtration barrier of the kidney along with the glomerular basement membrane (GBM), glomerular endothelial cells, and glycocalyx. Phenotypically, podocytes consist of a cell body and primary, microtubule-driven membrane extensions, as well as secondary extensions called foot processes1,2. The glomerular filtration barrier that filters urine from the blood is built of fenestrated endothelium, GBM, and a specialized type of intercellular junction that connects neighboring podocyte foot processes, called the slit diaphragm of podoctyes3. Under healthy conditions, proteins larger than albumin are retained from the filtration barrier due to their size and charge4.
Mutations in cytoskeletal- or podocyte-specific genes, as well as circulating factors affecting podocyte signaling pathways, are known to induce podocyte effacement, detachment, or apoptosis, resulting in proteinuria and glomerular sclerosis. In particular, cytoskeletal rearrangement, changes in podocyte polarity or damage of foot processes with an associated loss of slit junctions are&#160;pivotal5. Due to their terminally differentiated status, podocytes can hardly be replaced after detachment of the GBM. However, if podocytes are attached to the GBM, they can still recover from effacement and reform interdigitating foot processes6,7,8. Further understanding of the events that lead to podocyte damage in various glomerular disorders may provide novel therapeutic targets that will aid in developing treatments for these diseases. Podocyte damage is a hallmark of different glomerular diseases, including focal segmental glomerulosclerosis (FSGS), diabetic nephropathy, minimal change disease, and membranous glomerulonephropathy, requiring reliable podocyte ex vivo models to study the pathological mechanisms and potential treatment approaches for these diseases9,10. Podocytes can be studied ex vivo by classical primary cell culture based on the isolation of glomeruli by differential sieving11. However, due to the terminally differentiated state with limited proliferation capacity, most researchers use mouse or human ciPodocyte cell lines that express temperature-sensitive variants of the SV40 large T antigen. Alternatively, ciPodocytes are isolated from transgenic mice harboring the SV40 Tag immortalizing gene1,12.
CiPodocytes proliferate at 33 &#176;C, but enter growth arrest and start differentiating at 37 &#176;C13,14. It has to be kept in mind that experimental data obtained with these cells should be interpreted with certain caution, as the cells are generated using an unnatural gene insertion15. As these cells harbor an immortalizing gene, the cellular physiology is altered because of ongoing proliferation12. Podocyte cell lines generated by this approach have recently been questioned, as mouse, human, and rat ciPodocytes express less than 5% of synaptopodin and nephrin at the protein level, as well as NPHS1 and NPHS2 at the mRNA level&#160;compared to glomerular expression16. Moreover, most podocyte cell lines do not express nephrin17,18. Chittiprol et al. also described a significant difference in cell motility and responses to puromycin and doxorubicin in ciPodocytes16. Podocytes can be found in urine after detachment from the GBM in different glomerular diseases19,20,21,22. Viable urinary podocytes can be cultivated ex vivo for up to 2-3 weeks, but most cells undergo apoptosis23,24. Interestingly, podocytes are not only found in the urine of patients with glomerular disease but also in the urine of healthy subjects, most likely when they are senescent-again with a limited potential of replication in culture24. Furthermore, the urinary-derived podocyte number is limited, and the cells dedifferentiate in culture, show less foot processes, change morphology, and most importantly have limited proliferation capacity. The expression of podocyte-specific genes is absent, disappears within a few weeks, or varies among these cell clones. Some cells positive for the podocyte-specific marker co-expressed the marker of tubular epithelial cells or myofibroblasts and mesangial cells, which suggests dedifferentiation and/or transdifferentiation of the cultured urinary podocytes24,25.
Recently, the generation of ciPodocyte cell lines derived from the urine of patients and healthy volunteers by transduction with a thermo-sensitive SV40 large T antigen and hTERT has been described26. mRNA expression for synaptopodin, nestin, and CD2-associated&#160;protein was detected, but podocin mRNA was absent in all clones. In addition to the problems with urinary podocytes, these cells also contain the inserted immortalizing gene, resulting in the disadvantages discussed above.
In contrast, human induced pluripotent stem cells (hiPSCs) have a huge capacity to self-renew and differentiate into multiple cell types under appropriate conditions. It has been shown before that hiPSCs can serve as an almost unlimited source of podocytes27,28.
Here, a two-step protocol to generate patient-specific podocytes from dermal fibroblasts of skin punch biopsies with subsequent episomal reprogramming into hiPSCs and a final differentiation into hiPSC-derived podocytes is described (Figure 1).
<img alt="Figure 1" class="xfigimg" src="/files/ftp_upload/65364/65364fig01.jpg" /> 
Figure 1: Protocol to generate patient-specific hiPSC-derived podocytes. Graphical overview of the protocol to generate patient-specific podocytes from dermal fibroblasts of a skin biopsy by reprogramming into hiPSCs and differentiation into podocytes. <a href="https://www.jove.com/files/ftp_upload/65364/65364fig01large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
As a first step, somatic dermal fibroblasts were outgrown from a skin punch biopsy and reprogrammed into hiPSCs using an integration-free method by electroporation with plasmids expressing the transcription factors OCT3/4, KLF4, SOX2, and c-MYC29,30,31. Arising hiPSC colonies were subsequently selected and expanded. Differentiation began with the induction of the mesodermal lineage by activation of the WNT signaling pathway, followed by the generation of nephron progenitor cells that were still able to proliferate. Finally, the cells were differentiated into podocytes. In this procedure, we modified and combined previously published protocols for episomal reprogramming for the generation of hiPSCs by Bang et al.32 and Okita et al.33, as well as a protocol for the differentiation of hiPSCs into podocytes by Musah et al.28,34,35.
Indeed, podocytes generated by our protocol had a phenotype closer to podocytes in vivo, regarding the development of a distinct network of primary and secondary foot processes and the expression of podocyte-specific markers, like synaptopodin, podocin, and nephrin. With the use of hiPSC-derived podocytes, the patient&#39;s genetic background is maintained during reprogramming and differentiation. This enables patient-specific podocyte disease modelling and the discovery of potential therapeutic substances ex vivo in an almost unlimited cell number. Moreover, this protocol is minimally invasive, cost-efficient, ethically acceptable and may facilitate new avenues for drug development.

<table><tbody><tr><td>0.2 &amp;micro;m sterile filter</td><td>Rotilab</td><td>P668.1</td><td>for sterilization of differentiation medium</td></tr><tr><td>all-trans retinoic acid</td><td>Stem Cell Technologies</td><td>72262</td><td>supplement for differentiation</td></tr><tr><td>B27 supplement (50 x), serum free</td><td>Gibco</td><td>17504044</td><td>supplement for serum-free differentiation medium</td></tr><tr><td>BG iMatrix-511 Silk</td><td>biogems</td><td>RL511S</td><td>additional option of extracellular matrix reagent used in coating solution to coat cell culture plastics suitable for hiPSC culture</td></tr><tr><td>Bovine serum albumin (BSA)&amp;nbsp;</td><td>Roth</td><td>8076.4</td><td></td></tr><tr><td>CELLSTAR Filter Cap Cell Culture Flasks, T75, 250 mL</td><td>Greiner bio-one</td><td>82050-856</td><td>cell culture plastics suitable for fibroblast culture</td></tr><tr><td>CHIR99021 (5 mg)</td><td>Sigma-Aldrich</td><td>252917-06-9&amp;nbsp;</td><td>supplement for differentiation</td></tr><tr><td>Corning Matrigel hESC qualified matrix&amp;nbsp;</td><td>Corning</td><td>354277</td><td>additional option of extracellular matrix reagent used in coating solution to coat cell culture plastics suitable for hiPSC culture (solubilized basement membrane matrix)</td></tr><tr><td>countess Cell Counting Chamber Slides</td><td>Invitrogen</td><td>C10283</td><td>to count cells</td></tr><tr><td>countess II FL&amp;nbsp; Automated Cell Counter</td><td>Invitrogen</td><td></td><td>to count cells</td></tr><tr><td>cryoPure tubes, 2 ml, QuickSeal screw cap, white</td><td>Sarstedt</td><td>72380</td><td>cryovials for freezing of cells</td></tr><tr><td>dimethyl sulfoxide (DMSO)&amp;nbsp;</td><td>Roth</td><td>A994.1</td><td>for fibroblast freezing medium</td></tr><tr><td>DMEM/F12 (1:1) (1 x)</td><td>Gibco</td><td>11320074</td><td>basic medium for differentiation</td></tr><tr><td>DMEM/F12 + Glutamax</td><td>Gibco</td><td>10565018</td><td>basic medium for fibroblast medium</td></tr><tr><td>EVOS M5000 Imaging System</td><td>Thermo Fisher Scientific</td><td>AMF5000</td><td>phase contrast microscope</td></tr><tr><td>fetal bovine serum premium, inactivated (FCS)</td><td>PAN Biotech</td><td>P301902</td><td>serum for fibroblast medium, fibroblast freezing medium and podocyte maintenance medium</td></tr><tr><td>fisherbrand Electroporation Cuvettes Plus, 4 mm gap, 800 &amp;micro;L capacity, sterile</td><td>Fisherbrand</td><td>FB104</td><td>cuvette used for electroporation/episomal reprogramming of fibroblasts (4mm gap)</td></tr><tr><td>fluoromount-G Mounting Medium, with DAPI</td><td>Invitrogen</td><td>00-4959-52</td><td>mounting medium containing dapi</td></tr><tr><td>gauge needle (0.6 x 30 mm)</td><td>BD Microlance3</td><td>300700</td><td>for separation of hiPSC colonies into small pieces</td></tr><tr><td>human Recombinant Activin A Protein</td><td>78001.1</td><td>Stem cell technologies</td><td>supplement for differentiation</td></tr><tr><td>human recombinant bone morphogenetic protein 7 (BMP7)</td><td>Peprotech</td><td>120-03P</td><td>supplement for differentiation</td></tr><tr><td>human VEGF-165 Recombinant Protein</td><td>Thermo Scientific</td><td>PHC9394</td><td>supplement for differentiation</td></tr><tr><td>insulin-transferrin-selenium (ITS -G) (100 x)</td><td>Gibco</td><td>41400045</td><td>supplement for podocyte maintenance medium</td></tr><tr><td>LB medium</td><td>Roth</td><td>X964.1</td><td>for sterility test of hiPSC culture</td></tr><tr><td>lookOut Mycoplasma PCR Detection Kit</td><td>Sigma Aldrich</td><td>MP0035-1KT</td><td>commercial mycoplasma detection kit</td></tr><tr><td>microscope slides</td><td>Diagonal GmbH &amp;amp; Co.KG</td><td>21,102</td><td></td></tr><tr><td>microtube 1.5 mL&amp;nbsp;</td><td>Sarstedt</td><td>72706400</td><td></td></tr><tr><td>mTeSR1 Complete Kit</td><td>Stem Cell Technologies</td><td>85850</td><td>basic medium for serum-free hiPSC culture medium</td></tr><tr><td>nalgene freezing container Mr.Frosty</td><td>Roth</td><td>AC96.1&amp;nbsp;</td><td>to ensure optimal freezing conditions</td></tr><tr><td>normal goat serum</td><td>abcam</td><td>ab 7481</td><td>for preincubation solution and antibody diluent</td></tr><tr><td>nunc 24 well plates</td><td>Thermo Scientific</td><td>142485</td><td>cell culture plastics suitable for hiPSC culture</td></tr><tr><td>nunc 48 well plates&amp;nbsp;</td><td>Thermo Scientific</td><td>152640</td><td>cell culture plastics suitable for hiPSC culture</td></tr><tr><td>nunc 6 well plates&amp;nbsp;</td><td>Thermo Scientific</td><td>140685</td><td>cell culture plastics suitable for hiPSC culture</td></tr><tr><td>nunc EasYDish Dishes 100 mm</td><td>Thermo Scientific</td><td>150466</td><td>cell culture plastics suitable for hiPSC culture</td></tr><tr><td>nunc MicroWell 96-Well, Nunclon Delta-Treated, Flat-Bottom Microplate</td><td>Thermo Scientific</td><td>167008</td><td>cell culture plastics suitable for hiPSC culture</td></tr><tr><td>nutriFreez D10 Cryopreservation Medium</td><td>Sartorius</td><td>05-713-1E&amp;nbsp;</td><td>serum-free cryopreservation medium for cryopreservation of hiPSC and nephron progenitor cells</td></tr><tr><td>Opti-MEM</td><td>Gibco</td><td>11058021</td><td>electroporation medium&amp;nbsp;</td></tr><tr><td>pCXLE-hMLN</td><td>Addgene</td><td>#27079</td><td>plasmid for episomal reprogramming</td></tr><tr><td>pCXLE-hOCT3/4 plasmid</td><td>Addgene</td><td>#27077</td><td>plasmid for episomal reprogramming</td></tr><tr><td>pCXLE-hSK plasmid</td><td>Addgene</td><td>#27078</td><td>plasmid for episomal reprogramming</td></tr><tr><td>penicillin-streptomycin</td><td>Sigma-Aldrich</td><td>P4333-100ML</td><td>to avoid bacterial contamination</td></tr><tr><td>plastic coverslips</td><td>Sarstedt</td><td>&amp;nbsp; 83.1840.002</td><td>for immunofluorescent stainings of hiPSCs and hiPSC-derived podocytes</td></tr><tr><td>ROTI Histofix</td><td>Roth</td><td>P087.3</td><td>commercial paraformaldehyde (4 %) for fixation of cells</td></tr><tr><td>RPMI 1640 + L-Glutamine</td><td>Gibco</td><td>21875034</td><td>basic medium for podocyte maintenance medium</td></tr><tr><td>staining chamber StainTray Black lid</td><td>Roth</td><td>HA51.1</td><td></td></tr><tr><td>stemPro Accutase Cell Dissociation Reagent</td><td>Gibco</td><td>A1110501</td><td>enzymatic cell detachment solution used for dissociation of hiPSCs</td></tr><tr><td>sterile phosphate buffered saline (PBS) (1 x)</td><td>Gibco</td><td>14190094</td><td>used for washing and coating</td></tr><tr><td>sterile water</td><td>Roth</td><td>T1432</td><td></td></tr><tr><td>syringe without needle 20 mL</td><td>BD Plastipak</td><td>300629</td><td>to filter sterilize differentiation medium</td></tr><tr><td>TC dish 100 mm</td><td>Sarstedt</td><td>8,33,902</td><td>sterile cell culture plastics used for cutting the skin biopsy and fibroblast culture</td></tr><tr><td>TC dish 35 mm</td><td>Sarstedt</td><td>8,33,900</td><td>sterile cell culture plastics used for outgrowing fibroblasts from skin biopsy</td></tr><tr><td>triton X 100</td><td>Roth</td><td>3051.3</td><td>for preincubation solution&amp;nbsp;</td></tr><tr><td>trypan Blue Stain (0.4 %) for use with the Countess Automated Cell Counter</td><td>Invitrogen</td><td>T10282</td><td>to count cells</td></tr><tr><td>trypsin-EDTA (10 x)&amp;nbsp;</td><td>Biowest</td><td>X0930-100</td><td>dissociation reagent used for fibroblasts and nephron progenitor cells</td></tr><tr><td>tube 15 mL</td><td>Greiner bio-one</td><td>188271-N</td><td></td></tr><tr><td>tube 50 mL</td><td>Greiner bio-one</td><td>227261</td><td></td></tr><tr><td>vitronectin ACF</td><td>Sartorius</td><td>05-754-0002</td><td>extracellular matrix reagent used in coating solution to coat cell culture plastics suitable for hiPSC culture</td></tr><tr><td>Y-27632 dihydrochloride (10 mg)</td><td>Tocris</td><td>1254</td><td>to avoid apoptosis of hiPSCs during splitting</td></tr><tr><td>&lt;strong&gt;Primary antibodies&lt;/strong&gt;</td><td></td><td></td><td></td></tr><tr><td>OCT4&amp;nbsp;</td><td>Stem Cell Technologies</td><td>60093.1</td><td>pluripotency marker, dilution 1:200</td></tr><tr><td>SSEA-4</td><td>Stem Cell Technologies</td><td>60062FI.1</td><td>pluripotency marker, dilution 1:100</td></tr><tr><td>Ki67</td><td>Abcam</td><td>ab15580</td><td>proliferation marker, dilution 1:300</td></tr><tr><td>synaptopodin</td><td>Proteintech</td><td>21064-1-AP</td><td>podocyte-specific marker, dilution 1:200</td></tr><tr><td>nephrin</td><td>Progen</td><td>GP-N2</td><td>podocyte-specific marker, dilution 1:25</td></tr><tr><td>podocin</td><td>proteintech</td><td>20384-1-AP</td><td>podocyte-specific marker, dilution 1:100</td></tr><tr><td>&lt;strong&gt;Secondary antibodies&lt;/strong&gt;</td><td></td><td></td><td></td></tr><tr><td>goat anti-Guinea Pig IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor 555</td><td>Invitrogen</td><td>A21435</td><td>secondary anditbody, dilution 1:1000</td></tr><tr><td>alexa Fluor 647 Goat Anti-Rabbit SFX Kit, highly cross-adsorbed</td><td>Invitrogen</td><td>A31634</td><td>secondary anditbody, dilution 1:1000</td></tr><tr><td>donkey anti-Rabbit IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor 488</td><td>Invitrogen</td><td>A21206</td><td>secondary anditbody, dilution 1:1000</td></tr><tr><td>goat anti-Mouse IgG (H+L) Cross-Adsorbed Secondary Antibody, Alexa Fluor 555</td><td>Invitrogen</td><td>A21422</td><td>secondary anditbody, dilution 1:1000</td></tr><tr><td>goat anti-Mouse IgG (H+L) Cross-Adsorbed Secondary Antibody, Alexa Fluor 488</td><td>Invitrogen</td><td>A11001</td><td>secondary anditbody, dilution 1:1000</td></tr></tbody></table>

generation of patient-derived podocytes from skin biopsies

Podocytes are epithelial cells sitting on the urinary site of the glomerular filtration barrier that contribute to the selective filter function of the glomerulus. Mutations in podocyte-specific genes can cause focal segmental glomerulosclerosis (FSGS), and podocytes are also affected in many other primary and secondary nephropathies. Due to their differentiated nature, primary cell culture models are limited for podocytes.&#160;Therefore, commonly conditionally immortalized cells are used. However, these conditionally immortalized podocytes (ciPodocytes) have several limitations: the cells can dedifferentiate in culture, especially when they reach confluency, and several podocyte-specific markers are either only slightly or not expressed at all. This brings the use of ciPodocytes and their applicability for physiological, pathophysiological, and clinical reach into question. Here, we describe a protocol for the generation of human podocytes-including patient-specific podocytes-from a skin punch biopsy by episomal reprogramming of dermal fibroblasts into hiPSCs and subsequent differentiation into podocytes. These podocytes resemble in vivo podocytes much better in terms of morphological characteristics, like the development of foot processes and the expression of the podocyte-specific marker. Finally, yet importantly, these cells maintain patients&#39; mutations, resulting in an improved ex vivo model to study podocyte diseases and potential therapeutic substances in an individualized approach.

With this step-by-step protocol that combines episomal reprogramming and differentiation, it is possible to generate podocytes carrying a patient&#39;s mutation in a podocyte-relevant gene. This enables the analysis of disease-specific podocyte alterations ex vivo. The patient&#39;s genetic background is preserved during the protocol during all the different cell stages. In addition, the limitation of insufficient cell number of terminally differentiated non-proliferating podocytes can be overcome by using hiPSC-derived podocytes. Although it takes several months until hiPSC-podocytes are generated from outgrown dermal fibroblasts via reprogramming into hiPSCs and subsequent differentiation into podocytes, it is possible to freeze cells at three different steps of the protocol (Figure 2). Freezing is possible for fibroblasts, hiPSCs, and nephron progenitor cells after differentiation in nephron progenitor differentiation medium for 7 days. Therefore, the generation of working cell banks and large-scale experiments is possible.
<img alt="Figure 2" class="xfigimg" src="/files/ftp_upload/65364/65364fig02.jpg" /> 
Figure 2: Individual steps of the protocol through a phase contrast microscope.&#160;(A) Outgrown dermal fibroblasts. (B) hiPSC colony formation after reprogramming. (C) Selected hiPSC culture. (D) Mesoderm cells after 2 days of differentiation. (E) Nephron progenitor cells after 14 days of differentiation in nephron progenitor differentiation medium. (F) Terminal differentiated hiPSC-derived podocytes. Scale bars represent 300 &#181;m (A,B,D-F) and 150 &#181;m (C). The snowflake highlights possible freezing steps. <a href="https://www.jove.com/files/ftp_upload/65364/65364fig02large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
As the generated hiPSC-derived podocytes traverse a long protocol with drastic changes regarding cell type and morphology, cell characterization is obligatory. Cell morphology, like size and cell shape, as well as growth behavior, can be monitored using a phase contrast microscope. Fibroblasts present a long spindle-like phenotype with a size of 150 &#181;m to 300 &#181;m&#160;(Figure 2A). After reprogramming, colonies with 50 &#181;m&#160;small hiPSCs occur. These colonies display distinct borders and hiPSCs distinguished with a high nuclei-to-body ratio and increased proliferation rate (Figure 2C). Since podocytes are terminally differentiated cells, the proliferation rate decreases with progressive differentiation, and the cell morphology changes to 300 &#181;m&#160;large star-shaped podocytes with prominent foot processes (Figure 2F).
Confluency is a critical point of hiPSC culture, and spontaneous differentiation can appear when colonies grow too dense (Figure 3). These colonies must be removed before passaging by scraping the affected parts of the culture dish.
<img alt="Figure 3" class="xfigimg" src="/files/ftp_upload/65364/65364fig04.jpg" /> 
Figure 3: Examples of hiPSCs of different quality. Phase contrast images of successfully (A) reprogrammed hiPSC colonies and (B) selected hiPSCs, as well as (C) spontaneous differentiation, (D,E) non-hiPSC colonies, and (F) a too-dense hiPSC culture. Scale bars represent 300 &#181;m. <a href="https://www.jove.com/files/ftp_upload/65364/65364fig04large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
The different cell types of this protocol must be validated regarding the expression of a specific marker. After reprogramming, hiPSCs regain pluripotency capacity and express proliferation and pluripotency markers like SSEA4, OCT3/4, and Ki67 (Figure 4)38,39,40. It is known that reprogramming, as well as the lengthy culture of hiPSCs and differentiation, can lead to an abnormal karyotype, or rather induce mutations41. Therefore, the genetic background of the cultured cells should be monitored over time and at different passages by g-banding and whole exome sequencing.
<img alt="Figure 4" class="xfigimg" src="/files/ftp_upload/65364/65364fig03.jpg" /> 
Figure 4: Characterization of generated hiPSCs by immunofluorescence staining. Characterization of generated hiPSCs by staining for (A) the proliferative marker Ki67, as well as the pluripotency markers (B) OCT3/4 and (C) SSEA4. Scale bars represent 100 &#181;m. <a href="https://www.jove.com/files/ftp_upload/65364/65364fig03large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
Morphologically, hiPSC-derived podocytes appear star-shaped and express a distinct network of long primary and secondary foot processes compared to ciPodocytes (Figure 5). HiPSC-derived podocytes express podocyte-specific marker proteins like synaptopodin, nephrin, and podocin (Figure 6A-C)42.
<img alt="Figure 5" class="xfigimg" src="/files/ftp_upload/65364/65364fig05.jpg" /> 
Figure 5: Morphology of hiPSC-derived podocytes compared to ciPodocytes.&#160;Comparison of (A,B) hiPSC-derived podocytes from a healthy donor to (C,D) ciPodocytes regarding cell morphology and filopodia by using a phase contrast microscope (A,C) and scanning electron microscope (B,D). Scale bars represent 150 &#181;m (A,C) and 20 &#181;m (B,D). <a href="https://www.jove.com/files/ftp_upload/65364/65364fig05large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
Therefore, the comparison of hiPSC-derived podocytes not only from healthy donors, but also from patients with mutations in podocyte-specific genes, allows for individualized characterization of the patient&#39;s mutation ex vivo.
<img alt="Figure 6" class="xfigimg" src="/files/ftp_upload/65364/65364fig06.jpg" /> 
Figure 6: Characterization of a podocyte-specific marker in hiPSC-derived podocytes and ciPodocytes. Comparison of (A-C) hiPSC-derived podocytes from a healthy donor to (D-F) ciPodocytes regarding podocyte-specific marker proteins synaptopodin (A,D), nephrin (B,E), and podocin (C,F). Scale bars represent 50 &#181;m. <a href="https://www.jove.com/files/ftp_upload/65364/65364fig06large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
Table 1. Composition of all cell culture media and solutions used in the study. <a href="https://www.jove.com/files/ftp_upload/65364/Table 1_REv2.zip" target="_blank">Please click here to download this Table.</a>

Watch this Scientific Journal Video about Generation of Patient-Derived Podocytes from Skin Biopsies at JoVE.com

Author Spotlight: Generation of Patient-Derived Podocytes from Skin Biopsies  

This manuscript describes a two-step protocol to generate patient-specific podocytes from dermal fibroblasts via episomal reprogramming into human-induced pluripotent stem cells (hiPSCs) and subsequent differentiation into podocytes.

Generation of Patient-Derived Podocytes from Skin Biopsies

Podocytes are epithelial cells sitting on the urinary site of the glomerular filtration barrier that contribute to the selective filter function of the ...

generation-of-patient-derived-podocytes-from-skin-biopsies

Research

JoVE Journal

Biology

2.0K Views.  Friedrich-Alexander University (FAU) Erlangen-Nürnberg. This manuscript describes a two-step protocol to generate patient-specific podocytes from dermal fibroblasts via episomal reprogramming into human-induced pluripotent stem cells (hiPSCs) and subsequent differentiation into podocytes.

Video: Author Spotlight: Generation of Patient-Derived Podocytes from Skin Biopsies  

Generation of Single-Cell Suspensions from Mouse Neural Tissue

Within the nervous system, hundreds of neuronal and glial cell types have been described. Each specific cell type in the brain or spinal cord has a repertoire of cell surface molecules, or molecular determinants, through which it can be identified and characterized. Currently, robust cell identification and separation technologies require single-cell preparations to be generated while simultaneously limiting cell death and destruction of characteristic surface protein. The gentleMACS Dissociator, when used in combination with trypsin or papain-based dissociation kits, can effectively and gently dissociate brain tissue while preserving antigen epitopes and limiting cell loss. Standardized preparation of single-cell suspensions is achieved using C Tubes and optimized, preset gentleMACS Programs. Once generated, single-cell suspensions can be treated with monoclonal conjugates like Anti-Prominin-1 MicroBeads, which identify neural progenitors, or purified further using Myelin Removal Beads.

Dissociating cells from specific tissue types requires specific parameters for tissue aggitation to obtain a high volume of viable, culturable cells. The Miltenyi gentleMACS Dissociator optimizes this task with a simple, practical protocol. In this publication the use of this apparatus on nerual tissue is explained.

Within the nervous system, hundreds of neuronal and glial cell types have been described. Each specific cell type in the brain or spinal cord has a ...

Generation of 3D Skin Organoid from Cord Blood-derived Induced Pluripotent Stem Cells

The skin is the body&#8217;s largest organ and has many functions. The skin acts as a physical barrier and protector of the body and regulates bodily functions. Biomimetics is the imitation of the models, systems, and elements of nature for the purpose of solving complex human problems1. Skin biomimetics is a useful tool for in vitro disease research and in vivo regenerative medicine. Human induced pluripotent stem cells (iPSCs) have the characteristic of unlimited proliferation and the ability of differentiation to three germ layers. Human iPSCs are generated from various primary cells, such as blood cells, keratinocytes, fibroblasts, and more. Among them, cord blood mononuclear cells (CBMCs) have emerged as an alternative cell source from the perspective of allogeneic regenerative medicine. CBMCs are useful in regenerative medicine because human leukocyte antigen (HLA) typing is essential to the cell banking system. We provide a method for the differentiation of CBMC-iPSCs into keratinocytes and fibroblasts and for generation of a 3D skin organoid. CBMC-iPSC-derived keratinocytes and fibroblasts have characteristics similar to a primary cell line. The 3D skin organoids are generated by overlaying an epidermal layer onto a dermal layer. By transplanting this 3D skin organoid, a humanized mice model is generated. This study shows that a 3D human iPSC-derived skin organoid may be a novel, alternative tool for dermatologic research in vitro and in vivo.

We propose a protocol that shows how to differentiate induced pluripotent stem cell-derived keratinocytes and fibroblasts and generate a 3D skin organoid, using these keratinocytes and fibroblasts. This protocol contains an additional step of generating a humanized mice model. The technique presented here will improve dermatologic research.

The skin is the body&#8217;s largest organ and has many functions. The skin acts as a physical barrier and protector of the body and regulates bodily ...

Developmental Biology

Isolation and Culture of Adult Epithelial Stem Cells from Human Skin

The homeostasis of all self-renewing tissues is dependent on adult stem cells. As undifferentiated stem cells undergo asymmetric divisions, they generate daughter cells that retain the stem cell phenotype and transit-amplifying cells (TA cells) that migrate from the stem cell niche, undergo rapid proliferation and terminally differentiate to repopulate the tissue.
Epithelial stem cells have been identified in the epidermis, hair follicle, and intestine as cells with a high in vitro proliferative potential and as slow-cycling label-retaining cells in vivo 1-3. Adult, tissue-specific stem cells are responsible for the regeneration of the tissues in which they reside during normal physiologic turnover as well as during times of stress 4-5. Moreover, stem cells are generally considered to be multi-potent, possessing the capacity to give rise to multiple cell types within the tissue 6. For example, rodent hair follicle stem cells can generate epidermis, sebaceous glands, and hair follicles 7-9. We have shown that stem cells from the human hair follicle bulge region exhibit multi-potentiality 10.
Stem cells have become a valuable tool in biomedical research, due to their utility as an in vitro system for studying developmental biology, differentiation, tumorigenesis and for their possible therapeutic utility. It is likely that adult epithelial stem cells will be useful in the treatment of diseases such as ectodermal dysplasias, monilethrix, Netherton syndrome, Menkes disease, hereditary epidermolysis bullosa and alopecias 11-13. Additionally, other skin problems such as burn wounds, chronic wounds and ulcers will benefit from stem cell related therapies 14,15. Given the potential for reprogramming of adult cells into a pluripotent state (iPS cells)16,17, the readily accessible and expandable adult stem cells in human skin may provide a valuable source of cells for induction and downstream therapy for a wide range of disease including diabetes and Parkinson's disease.

A rapid, robust way of isolating viable adult epithelial stem cells from human skin is described. The method utilizes enzymatic digestion of skin collagen matrix , followed by plucking of hair follicles and isolation of single cell suspensions or tissue fragments for cell culture.

The homeostasis of all self-renewing tissues is dependent on adult stem cells. As undifferentiated stem cells undergo asymmetric divisions, they generate ...

Guided Differentiation of Mature Kidney Podocytes from Human Induced Pluripotent Stem Cells Under Chemically Defined Conditions

Kidney disease affects more than 10% of the global population and costs billions of dollars in federal expenditures. The most severe forms of kidney disease and eventual end-stage renal failure are often caused by the damage to the glomerular podocytes, which are the highly specialized epithelial cells that function together with endothelial cells and the glomerular basement membrane to form the kidney&#8217;s filtration barrier. Advances in renal medicine have been hindered by the limited availability of primary tissues and the lack of robust methods for the derivation of functional human kidney cells, such as podocytes. The ability to derive podocytes from renewable sources, such as stem cells, could help advance current understanding of the mechanisms of human kidney development and disease, as well as provide new tools for therapeutic discovery. The goal of this protocol was to develop a method to derive mature, post-mitotic podocytes from human induced pluripotent stem (hiPS) cells with high efficiency and specificity, and under chemically defined conditions. The hiPS cell-derived podocytes produced by this method express lineage-specific markers (including nephrin, podocin, and Wilm&#8217;s Tumor 1) and exhibit the specialized morphological characteristics (including primary and secondary foot processes) associated with mature and functional podocytes. Intriguingly, these specialized features are notably absent in the immortalized podocyte cell line widely used in the field, which suggests that the protocol described herein produces human kidney podocytes that have a developmentally more mature phenotype than the existing podocyte cell lines typically used to study human kidney biology.

Presented here is a chemically defined protocol for the derivation of human kidney podocytes from induced pluripotent stem cells with high efficiency (&#62;90%) and independent of genetic manipulations or subpopulation selection. This protocol produces the desired cell type within 26 days and could be useful for nephrotoxicity testing and disease modeling.

Kidney disease affects more than 10% of the global population and costs billions of dollars in federal expenditures. The most severe forms of kidney ...

Bioengineering

Generation of Mice Derived from Induced Pluripotent Stem Cells

The production of induced pluripotent stem cells (iPSCs) from somatic cells provides a means to create valuable tools for basic research and may also produce a source of patient-matched cells for regenerative therapies. iPSCs may be generated using multiple protocols and derived from multiple cell sources. Once generated, iPSCs are tested using a variety of assays including immunostaining for pluripotency markers, generation of three germ layers in embryoid bodies and teratomas, comparisons of gene expression with embryonic stem cells (ESCs) and production of chimeric mice with or without germline contribution2. Importantly, iPSC lines that pass these tests still vary in their capacity to produce different differentiated cell types2. This has made it difficult to establish which iPSC derivation protocols, donor cell sources or selection methods are most useful for different applications.
The most stringent test of whether a stem cell line has sufficient developmental potential to generate all tissues required for survival of an organism (termed full pluripotency) is tetraploid embryo complementation (TEC)3-5. Technically, TEC involves electrofusion of two-cell embryos to generate tetraploid (4n) one-cell embryos that can be cultured in vitro to the blastocyst stage6. Diploid (2n) pluripotent stem cells (e.g. ESCs or iPSCs) are then injected into the blastocoel cavity of the tetraploid blastocyst and transferred to a recipient female for gestation (see Figure 1). The tetraploid component of the complemented embryo contributes almost exclusively to the extraembryonic tissues (placenta, yolk sac), whereas the diploid cells constitute the embryo proper, resulting in a fetus derived entirely from the injected stem cell line.
Recently, we reported the derivation of iPSC lines that reproducibly generate adult mice via TEC1. These iPSC lines give rise to viable pups with efficiencies of 5-13%, which is comparable to ESCs3,4,7 and higher than that reported for most other iPSC lines8-12. These reports show that direct reprogramming can produce fully pluripotent iPSCs that match ESCs in their developmental potential and efficiency of generating pups in TEC tests. At present, it is not clear what distinguishes between fully pluripotent iPSCs and less potent lines13-15. Nor is it clear which reprogramming methods will produce these lines with the highest efficiency. Here we describe one method that produces fully pluripotent iPSCs and "all- iPSC" mice, which may be helpful for investigators wishing to compare the pluripotency of iPSC lines or establish the equivalence of different reprogramming methods.

Generating induced pluripotent stem cell (iPSC) lines produces lines of differing developmental potential even when they pass standard tests for pluripotency. Here we describe a protocol to produce mice derived entirely from iPSCs, which defines the iPSC lines as possessing full pluripotency1.

The production of induced pluripotent stem cells (iPSCs) from somatic cells provides a means to create valuable tools for basic research and may also ...

Isogenic Kidney Glomerulus Chip Engineered from Human Induced Pluripotent Stem Cells

Chronic kidney disease (CKD) affects 15% of the U.S. adult population, but the establishment of targeted therapies has been limited by the lack of functional models that can accurately predict human biological responses and nephrotoxicity. Advancements in kidney precision medicine could help overcome these limitations. However, previously established in vitro models of the human kidney glomerulus-the primary site for blood filtration and a key target of many diseases and drug toxicities-typically employ heterogeneous cell populations with limited functional characteristics and unmatched genetic backgrounds. These characteristics significantly limit their application for patient-specific disease modeling and therapeutic discovery. 
This paper presents a protocol that integrates human induced pluripotent stem (iPS) cell-derived glomerular epithelium (podocytes) and vascular endothelium from a single patient to engineer an isogenic and vascularized microfluidic kidney glomerulus chip. The resulting glomerulus chip is comprised of stem cell-derived endothelial and epithelial cell layers that express lineage-specific markers, produce basement membrane proteins, and form a tissue-tissue interface resembling the kidney's glomerular filtration barrier. The engineered glomerulus chip selectively filters molecules and recapitulates drug-induced kidney injury. The ability to reconstitute the structure and function of the kidney glomerulus using isogenic cell types creates the opportunity to model kidney disease with patient specificity and advance the utility of organs-on-chips for kidney precision medicine and related applications.

Presented here is a protocol to engineer a personalized organ-on-a-chip system that recapitulates the structure and function of the kidney glomerular filtration barrier by integrating genetically matched epithelial and vascular endothelial cells differentiated from human induced pluripotent stem cells. This bioengineered system can advance kidney precision medicine and related applications.

Chronic kidney disease (CKD) affects 15% of the U.S. adult population, but the establishment of targeted therapies has been limited by the lack of ...

Rapid Generation of Amyloid from Native Proteins In vitro

Proteins carry out crucial tasks in organisms by exerting functions elicited from their specific three dimensional folds. Although the native structures of polypeptides fulfill many purposes, it is now recognized that most proteins can adopt an alternative assembly of beta-sheet rich amyloid. Insoluble amyloid fibrils are initially associated with multiple human ailments, but they are increasingly shown as functional players participating in various important cellular processes. In addition, amyloid deposited in patient tissues contains nonproteinaceous components, such as nucleic acids and glycosaminoglycans (GAGs). These cofactors can facilitate the formation of amyloid, resulting in the generation of different types of insoluble precipitates. By taking advantage of our understanding how proteins misfold via an intermediate stage of soluble amyloid precursor, we have devised a method to convert native proteins to amyloid fibrils in vitro. This approach allows one to prepare amyloid in large quantities, examine the properties of amyloid generated from specific proteins, and evaluate the structural changes accompanying the conversion.

Rapid Generation of Amyloid from Native Proteins In vitro

Proteins can either adopt a native structure or misfold into insoluble amyloid. Conditions that favor the misfolding pathway lead to the formation of different types of amyloid fibrils. The methods described here allow rapid conversion of native proteins into amyloid in vitro.

Proteins carry out crucial tasks in organisms by exerting functions elicited from their specific three dimensional folds. Although the native structures ...

Generation of Myospheres From hESCs by Epigenetic Reprogramming

Generation of a homogeneous and abundant population of skeletal muscle cells from human embryonic stem cells (hESCs) is a requirement for cell-based therapies and for a "disease in a dish" model of human neuromuscular diseases. Major hurdles, such as low abundance and heterogeneity of the population of interest, as well as a lack of protocols for the formation of three-dimensional contractile structures, have limited the applications of stem cells for neuromuscular disorders. We have designed a protocol that overcomes these limits by ectopic introduction of defined factors in hESCs - the muscle determination factor MyoD and SWI/SNF chromatin remodeling complex component BAF60C - that are able to reprogram hESCs into skeletal muscle cells. Here we describe the protocol established to generate hESC-derived myoblasts and promote their clustering into tridimensional miniaturized structures (myospheres) that functionally mimic miniaturized skeletal muscles7.

Here, we describe a protocol based on epigenetic reprogramming of human embryonic stem cells (hESCs) toward generating a homogeneous population of skeletal muscle progenitors that under permissive culture conditions form three-dimensional clusters of contractile myofibers (myospheres), which recapitulate biological features of human skeletal muscles.

Generation of a homogeneous and abundant population of skeletal muscle cells from human embryonic stem cells (hESCs) is a requirement for cell-based ...

Single-channel Analysis and Calcium Imaging in the Podocytes of the Freshly Isolated Glomeruli

Podocytes (renal glomerular epithelial cells) are known to regulate glomerular permeability and maintain glomerular structure; a key role for these cells in the pathogenesis of various renal diseases has been established since podocyte injury leads to proteinuria and foot process effacement. It was previously reported that various endogenous agents may cause a dramatic overload in intracellular Ca2+ concentration in podocytes, presumably leading to albuminuria, and this likely occurs via calcium-conducting ion channels. Therefore, it appeared important to study calcium handling in the podocytes both under normal conditions and in various pathological states. However, available experimental approaches have remained somewhat limited to cultured and transfected cells. Although they represent a good basic model for such studies, they are essentially extracted from the native environment of the glomerulus. Here we describe the methodology of studying podocytes as a part of the freshly isolated whole glomerulus. This preparation retains the functional potential of the podocytes, which are still attached to the capillaries; therefore, podocytes remain in the environment that conserves the major parts of the glomeruli filtration apparatus. The present manuscript elaborates on two experimental approaches that allow 1) real-time detection of calcium concentration changes with the help of ratiometric confocal fluorescence microscopy, and 2) the recording of the single ion channels activity in the podocytes of the freshly isolated glomeruli. These methodologies utilize the advantages of the native environment of the glomerulus that enable researchers to resolve acute changes in the intracellular calcium handling in response to applications of various agents, measure basal concentration of calcium within the cells (for instance, to evaluate disease progression), and assess and manipulate calcium conductance at the level of single ion channels.

Changes in the intracellular calcium levels in the podocytes are one of the most important means to control the filtration function of glomeruli. Here we explain a high-throughput approach that allows detection of real-time calcium handling and single ion channels activity in the podocytes of the freshly isolated glomeruli.

Podocytes (renal glomerular epithelial cells) are known to regulate glomerular permeability and maintain glomerular structure; a key role for these cells ...

Deriving Human Kidney Podocytes from Induced Pluripotent Stem Cells: A Procedure for Directed Differentiation of Mature Kidney Podocytes from Stem Cells

Source: Burt, M. et al. <a href="https://www.jove.com/video/61299" target="_blank">Guided Differentiation of Mature Kidney Podocytes from Human Induced Pluripotent Stem Cells Under Chemically Defined Conditions.</a> J. Vis. Exp. (2020)
In this video, we describe the protocol to derive human kidney podocytes from induced pluripotent stem cells through cell differentiation under defined chemical conditions. The generated podocytes can be used for nephrotoxicity testing and disease modeling.

Source: Burt, M. et al. Guided Differentiation of Mature Kidney Podocytes from Human Induced Pluripotent Stem Cells Under Chemically Defined Conditions. ...

Generation of Patient-Derived Podocytes from Skin Biopsies

Summary

Explore More Videos

Chapters in this video

Generation of Single-Cell Suspensions from Mouse Neural Tissue

Generation of 3D Skin Organoid from Cord Blood-derived Induced Pluripotent Stem Cells

Isolation and Culture of Adult Epithelial Stem Cells from Human Skin

Guided Differentiation of Mature Kidney Podocytes from Human Induced Pluripotent Stem Cells Under Chemically Defined Conditions

Generation of Mice Derived from Induced Pluripotent Stem Cells

Isogenic Kidney Glomerulus Chip Engineered from Human Induced Pluripotent Stem Cells

Rapid Generation of Amyloid from Native Proteins In vitro

Generation of Myospheres From hESCs by Epigenetic Reprogramming

Single-channel Analysis and Calcium Imaging in the Podocytes of the Freshly Isolated Glomeruli

Deriving Human Kidney Podocytes from Induced Pluripotent Stem Cells: A Procedure for Directed Differentiation of Mature Kidney Podocytes from Stem Cells